Latest news with #US-patented
Business Upturn
06-08-2025
- Health
- Business Upturn
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
By GlobeNewswire Published on August 6, 2025, 03:25 IST HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) — Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance expands the use of its RS001 cardio-respiratory wearable to home environments and includes approval for its connected care platform marketed as 1Bio™. Illustrative Image of Respiree's RS001 Wearable With its Connected Care 1Bio™ Platform The RS001 is a chest-worn device that directly measures respiration and offers passive cardio-respiratory monitoring. Originally cleared for in-patient clinical use, the RS001's use in home settings marks a significant step toward more accessible and preventive healthcare. The device connects to a cellular hub, which enables data to be visualized in real time via the connected care 1Bio™ dashboard. 'Respiration is the most predictive vital sign for clinical deterioration, yet it remains underutilized – particularly outside hospital settings,' said Dr. Gurpreet Singh, CEO and Founder of Respiree. 'This FDA 510(k) extension allows healthcare systems to passively and accurately monitor leading indicators in the home, enabling earlier interventions and reducing the overall burden on healthcare infrastructure.' The announcement follows Respiree's recent US$11.6 million Series A financing round, led by We Venture Capital and ClavystBio, which will accelerate development toward potential regulatory approvals and global market expansion. Respiree also announced plans to pursue additional FDA clearances for its proprietary AI software, aiming to integrate artificial intelligence models into the 1Bio™ platform for both inpatient and home-based care. 'These are exciting times for us,' added Dr. Singh. 'Our first 510(k) was for the wearable; this second one is for the platform. We are now focused on bringing our flagship AI models into the fold as a Software as a Medical Device (SaMD).' About Respiree Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated artificial intelligence (AI) for managing disease progression across healthcare's care continuum. The 1Bio™ platform by Respiree™ uses data from the EHR and its proprietary US-patented and FDA-cleared sensors to longitudinal measure and track disease progression. Respiree™ is now available in U.S., Australia and Asia-Pacific (APAC). Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutics Goods Administration and has received the 510k clearance from the United States Food and Drug Administration (FDA). ( Media Enquiries Evangeline Fu Administrative Manager Respiree Pte Ltd Email: [email protected] A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Time of India
24-07-2025
- Health
- Time of India
Hybrid Endoscopic-Microscopic ENT skill lab inaugurated at Pune hospital
Dr. Yashraj Patil with dignitaries from Dr. D. Y. Patil Medical College, Hospital & Research Centre at the launch of the EndoPlay Skill Lab PUNE: A city-based hospital inaugurated a first of its kind Hybrid Endoscopic & Microscopic ENT Skill Lab – the EndoPlay Skill Lab – equipped with the US-patented EndoHold system for two-handed endoscopic surgery. This milestone was marked by the successful completion of the first-ever Hybrid Temporal Bone Dissection Workshop, training 20 select ENT surgeons and postgraduates from across India. The EndoPlay Skill Lab, inaugurated at Dr. D. Y. Patil Medical College, Hospital & Research Centre, is a fully integrated cadaveric dissection unit that bridges the gap between traditional microscopy and modern two-handed endoscopic techniques. At its core lies the EndoHold system — a globally patented innovation developed by Dr. Mubarak Muhamed Khan, Dr. Sapna Parab and Dr. Shirin Khan. The lab also houses over 15 additional surgical innovations from Dr. Khan's Creations, offering an unparalleled hands-on experience in otologic and neuro-otologic surgery. The lab was inaugurated by Dr. Yashraj Patil in the presence of Dr. Rekha Arcot, Dean of the medical college. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo 'The EndoPlay Skill Lab is a landmark addition to our academic ecosystem. It offers students and surgeons the unique advantage of mastering both microscopic and endoscopic ENT techniques in one integrated environment. This kind of immersive, hands-on training empowers our learners to not only meet but exceed global standards in surgical care,' said Dr. Arcot. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune Dr. Mayur Ingale, Professor, Department of Otorhinolaryngology, said 'The EndoPlay Skill Lab is a game-changer in ENT surgical training. For the first time, we are able to offer a hybrid platform that allows both microscopic and two-handed endoscopic dissection in a cadaveric setting.' As ENT surgery evolves into the era of minimal access and advanced reconstruction. The EndoPlay Skill Lab will now serve as the dissection hub for the upcoming International ENT Conference – SEOCON 2025, scheduled from 11–14 September at Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune. Surgeons from across the globe will have an opportunity to witness and experience this cutting-edge hybrid training ecosystem. 'This skill lab is not just an infrastructure; it is a visionary step that will pave the way for global excellence in ENT surgical training. We are proud that our institution is leading this transformation,' said Dr. Yashraj Patil, Trustee & Treasurer, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune. Dr. P. D. Patil, Chancellor, said 'At our institution, we are proud of our legacy in shaping future healthcare leaders. Staying true to that legacy, we are constantly bringing in the best — be it in education, infrastructure or innovation. Setting up progressive labs like the EndoPlay Skill Lab reflects our commitment to empowering faculty and students with world-class tools that inspire learning, research and excellence on a global scale. ' Dr. Bhagyashree Patil, Pro-Chancellor, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, said 'At Dr. D. Y. Patil Medical College, Hospital & Research Centre, we believe in creating future-ready medical professionals by embracing innovation in education. The launch of the world's first hybrid ENT skill lab is a testament to our commitment to transformative learning. It's a proud moment for us to see India set a global precedent in surgical training, right here in Pune. '
Fashion Value Chain
24-07-2025
- Health
- Fashion Value Chain
First Hybrid Endoscopic-Microscopic ENT Skill Lab Inaugurated at Dr. D. Y. Patil Medical College, Hospital & Research Centre
A revolutionary leap in surgical education unfolded in Pune as Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune, proudly inaugurated the world's first Hybrid Endoscopic & Microscopic ENT Skill Lab – the EndoPlay Skill Lab – equipped with the US-patented EndoHold system for two-handed endoscopic surgery. This milestone was marked by the successful completion of the first-ever Hybrid Temporal Bone Dissection Workshop, training 20 select ENT surgeons and postgraduates from across India. Hon'ble Dr. Yashraj Patil with dignitaries from Dr. D.â¯Y. Patil Medical College, Hospital & Research Centre at the launch of the EndoPlay Skill Lab This pioneering initiative was made possible by the visionary leadership of Hon'ble Dr. P. D. Patil, Chancellor; Hon'ble Dr. Bhagyashree Patil, Pro-Chancellor; and Hon'ble Dr. Yashraj Patil, Trustee & Treasurer of Dr. D. Y. Patil Vidyapeeth, Pimpri. Their foresight and unwavering support transformed this innovative concept into a state-of-the-art surgical training facility for the Department of ENT & Head-Neck Surgery. The EndoPlay Skill Lab is a fully integrated cadaveric dissection unit that bridges the gap between traditional microscopy and modern two-handed endoscopic techniques. At its core lies the EndoHold system – a globally patented innovation developed by Dr. Mubarak Muhamed Khan, Dr. Sapna Parab and Dr. Shirin Khan. The lab also houses over 15 additional surgical innovations from Dr. Khan's Creations, offering an unparalleled hands-on experience in otologic and neuro-otologic surgery. The lab was inaugurated by Dr. Yashraj Patil in the presence of Dr. Rekha Arcot, Dean of the medical college. The success of the first workshop owes much to the leadership of Prof. & HOD Dr. Mayur Ingale, and national faculties including Prof. Shashikant Mhashal (HBT Medical College, Mumbai), Prof. Vinod Shinde (Dr. D. Y. Patil Medical College, Hospital & Research Centre), Dr. Kinnari Rathod and Dr. Rizwan Memon (Ahmedabad). Hon'ble Dr. P. D. Patil, Chancellor, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, said,'At our institution, we are proud of our legacy in shaping future healthcare leaders. Staying true to that legacy, we are constantly bringing in the best – be it in education, infrastructure or innovation. Setting up progressive labs like the EndoPlay Skill Lab reflects our commitment to empowering faculty and students with world-class tools that inspire learning, research and excellence on a global scale.' Hon'ble Dr. Bhagyashree Patil, Pro-Chancellor, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, said,'At Dr. D. Y. Patil Medical College, Hospital & Research Centre, we believe in creating future-ready medical professionals by embracing innovation in education. The launch of the world's first hybrid ENT skill lab is a testament to our commitment to transformative learning. It's a proud moment for us to see India set a global precedent in surgical training, right here in Pune.' Upcoming Global Platform: SEOCON 25 The EndoPlay Skill Lab will now serve as the dissection hub for the upcoming International ENT Conference – SEOCON 2025, scheduled from 11-14 September at Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune. Surgeons from across the globe will have an opportunity to witness and experience this cutting-edge hybrid training ecosystem. 'This skill lab is not just an infrastructure; it is a visionary step that will pave the way for global excellence in ENT surgical training. We are proud that our institution is leading this transformation,' said Dr. Yashraj Patil, Trustee & Treasurer, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune. 'The EndoPlay Skill Lab is a landmark addition to our academic ecosystem. It offers students and surgeons the unique advantage of mastering both microscopic and endoscopic ENT techniques in one integrated environment. This kind of immersive, hands-on training empowers our learners to not only meet but exceed global standards in surgical care,' said Dr. Rekha Arcot, Dean, Dr. D. Y. Patil Medical College, Hospital & Research Centre. Dr. Mayur Ingale, Professor, Department of Otorhinolaryngology, Dr D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune, said, 'The EndoPlay Skill Lab is a game-changer in ENT surgical training. For the first time, we are able to offer a hybrid platform that allows both microscopic and two-handed endoscopic dissection in a cadaveric setting. This level of hands-on learning is unprecedented in India. I am deeply grateful to our visionary management for their support in turning this ambitious idea into a world-class reality.' As ENT surgery evolves into the era of minimal access and advanced reconstruction, the establishment of the EndoPlay Hybrid Skill Lab in Pune signals India's leadership in training the next generation of otologic surgeons with precision, innovation and global standards. About Dr. D. Y. Patil Medical College, Hospital &Research Centre, Pimpri, Pune Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune follows international benchmarks that are performance-driven as well as patient-centric, strongly backed by evidence-based medical expertise. We are NABH and NABL accredited and have been certified as a Green Hospital by the Association of Healthcare Providers India (AHPI). Additionally, we hold the 11th rank in the National Institutional Ranking Framework (NIRF). The university has been awarded A++ status by the National Assessment and Accreditation Council (NAAC) and is an ISO 2015 certified organization (ISO 9001: 2015). For more information visit Facebook: Dr D Y Patil Medical College, Hospital and Research Centre Instagram:
India Today
27-06-2025
- Health
- India Today
All you need to know about India's new wave of cosmetic surgery
What if beauty wasn't about chasing trends, but rediscovering your best self? In a world of filters, facial symmetry apps, and influencer aesthetics, cosmetic surgery in India is undergoing a quiet revolution—one that blends science, identity, and cultural nuance. No longer cloaked in taboo, aesthetic procedures are becoming mainstream, especially amongst India's urban middle Today spoke with Dr Debraj Shome, Co-founder and Director of one of India's leading multi-city The Esthetic Clinics , to explore how personalised cosmetic interventions are shaping a more confident, self-aware generation—one tweak at a time. From skin boosters to facial architecture tailored to Indian features, this is the new face of beauty: subtle, preventative, and deeply MINDSETS: COSMETIC SURGERY AS SELF-CARE, NOT VANITYAccording to Dr Shome, the past two decades have seen a significant transformation. 'Today's urban middle class sees cosmetic procedures not as vanity, but as smart self-investment,' he says. His patients range from young professionals to older individuals, all seeking natural-looking enhancements. Preventive treatments have surged. 'People in their twenties and thirties are choosing early interventions—Botox, advanced skin boosters, thread lifts, and our proprietary hair restoration therapy—to delay ageing instead of reversing it later,' he AESTHETICS FOR INDIA'S ETHNIC DIVERSITYFacial architecture, a foundational principle in Dr Shome's practice, requires an understanding of bone structure, soft tissue, and proportional harmony. With patients from across India's regions, he has developed a culturally sensitive approach.'Aesthetic ideals vary dramatically across the country. From the sculptural elegance of North Indian features to the fine angularity in the Northeast, we never use a one-size-fits-all formula,' he says. 'Each treatment plan is customised, not to Western standards, but to highlight what's inherently beautiful in each individual.'advertisementSKIN-DEEP SCIENCE: WORKING WITH INDIAN COMPLEXIONSIndian skin types—typically rich in melanin—demand unique treatment protocols. 'Our skin is more prone to hyperpigmentation and scarring,' says Dr Shome. He has tailored protocols for lasers, peels, and injectables to suit these needs.'From IPL and targeted fillers to customised rejuvenation therapies, every procedure is adjusted for safety and efficacy. When contouring Indian features, we consider broader mandibles or fuller cheeks—our approach is always structural, not superficial.'The demand for subtle, non-surgical procedures has overtaken traditional cosmetic surgeries. 'Earlier, patients wanted significant transformations—now they want small adjustments that preserve authenticity,' he dermal fillers, thread lifts, and under-eye rejuvenation are among the most requested. His signature hair therapy, a US-patented innovation for hair restoration, is also seeing high demand. 'Our goal is to refresh, not erase. It's about long-term confidence, not short-term correction.'CULTURAL INTEGRITY IN AESTHETIC OUTCOMESRespecting cultural identity is central to Dr Shome's practice. Consultations go beyond medical assessments—they involve discussions about heritage, regional beauty ideals, and personal values.'For instance, we design rhinoplasties that preserve ethnic contours while offering refinement. In facial contouring, the aim is not standardisation, but celebration of individuality. When someone says 'you look amazing' without pinpointing what changed, we've done it right.'SAFETY AND PRECISION THROUGH TECHNOLOGYadvertisementAdvancements like 3D facial scanning and AI-powered skin diagnostics have brought unprecedented precision. 'We use high-resolution imaging and smart injectable systems to plan treatments with millimetre accuracy,' says Dr patented hair treatment, developed after rigorous research, has already benefited patients across 10+ countries. 'Technology is allowing us to combine artistry with data-backed safety, making results not only beautiful but reliable.'THE FILTER EFFECT: COUNSELLING PATIENTS IN THE VIRAL ERAWith social media shaping beauty ideals, Dr Shome often has to educate patients. 'Many come in with filtered selfies or viral trends that don't suit their facial structure,' he emphasises consultation and education. 'We guide patients toward realistic goals. Whether it's our refined jawline contouring or nose reshaping techniques, the result should be enhancement, not transformation. Authenticity matters more than trends.'TRADITIONAL VALUES, CONTEMPORARY TECHNIQUESIndian beauty ideals have always prized grace, proportion, and subtlety—qualities that align well with modern surgical principles. 'We help patients understand how small refinements can amplify traditional features,' says Dr philosophy, he says, bridges generational expectations. 'A mother may want her daughter to retain family features, while the daughter wants subtle enhancements—we find a balance that honours both.'advertisementDEMAND BEYOND METROS: THE NEW FRONTIERThe demand for cosmetic care is growing in smaller cities. 'Patients from Tier 2 and Tier 3 cities are informed, confident, and committed. Word-of-mouth success and social proof are driving acceptance,' he clinic network has expanded accordingly, with consistent quality and protocols. 'We're reaching regions where cosmetic care was once unthinkable. It's no longer luxury—it's part of self-care.'ADVICE FOR FIRST-TIME PATIENTSDr Shome's message to those considering aesthetic treatment is clear: 'Start with the right reasons. Do it for yourself—not others. Choose certified professionals, understand the risks, and be patient with the process.'With over two decades of global training, research publications, and clinical innovations behind him, he views every treatment as a collaborative journey. 'It's not about trends—it's about helping people become more confident, more themselves.'- EndsMust Watch
Korea Herald
14-02-2025
- Business
- Korea Herald
Daewoong secures largest Latin America deal for Nabota
Daewoong Pharmaceutical announced Friday that it had signed a 180 billion won ($135 million) botulinum toxin export contract, marking the largest deal it has ever secured in the Latin American market. The company inked a five-year export contract for Nabota with its Brazilian partner, Moksha8 Pharmaceuticals, marking a tenfold increase from their 2018 deal worth 18 billion won. Brazil is the world's third-largest medical aesthetics market, following the United States and China, and is also known as the leading country in Latin America for botulinum toxin sales. According to market research firm Mordor Intelligence, the Brazilian botulinum toxin market has been growing steadily at an annual rate of 9.7 percent. This year, it is expected to reach some $228 million. Moksha8 Pharmaceuticals plans to strengthen its presence in Brazil with the Nabota 200-unit product, a high-dose version that obtained approval last month. Daewoong Pharmaceutical expects that the product's launch will broaden customer options for large hospitals and clinics with a high patient volume, as they favor high-dose products. Meanwhile, the company aims to leverage its success in Brazil to strengthen Nabota's brand recognition across Latin America. The company's botulinum toxin has already made successful inroads into major South American markets such as Argentina, Chile and Peru. Globally, Nabota has received product approval in 69 countries and established partnerships in over 80 countries. Nabota is a premium botulinum toxin manufactured using Korea and US-patented Hi-Pure Technology, and a vacuum-drying process, ensuring a high purity of over 98 percent. It delivers fast and precise effects while minimizing the occurrence of inactive toxins that could cause resistance. "The contract demonstrates Nabota's global competitiveness in the botulinum toxin market," said Yoon Joon-soo, head of Daewoong Pharmaceutical's Nabota Business Division. 'We will further expand our presence in Brazil while actively targeting key Latin American markets such as Argentina, Chile and Peru.'
